Picture of Vicore Pharma Holding AB logo

VICO Vicore Pharma Holding AB Balance Sheet

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Vicore Pharma Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments3193712624831,156
Net Total Accounts Receivable
Net Total Receivables5.351.422.183.2419.8
Prepaid Expenses
Total Current Assets3283782704961,203
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.2520.4010.1170.0250
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets4074513384981,203
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities48.165.746.44172.9
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities5267.948.942.473.8
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity3553832894551,129
Total Liabilities & Shareholders' Equity4074513384981,203
Total Common Shares Outstanding